← Eichor
Condition: Haematological Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Haematological Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma
Phase N/A · 1 location(s) · The Royal Wolverhampton Hospitals NHS Trust · NCT04234022oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05170347APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU
NA · 1 location(s) · Centre Hospitalier Régional Metz-Thionville · NCT05475600Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Phase 2/Phase 3 · 3 location(s) · Monash University · NCT07202052Pulsed Electromagnetic Fields in Preventing Physical Deconditioning in Patients Undergoing Prolonged Hospitalization
NA · 2 location(s) · National University Hospital, Singapore · NCT06744764Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06829654Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · 20 location(s) · University Hospital, Clermont-Ferrand · NCT04935684A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
Phase 1 · 3 location(s) · Cullgen (Shanghai),Inc · NCT07347171Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · 39 location(s) · CellCentric Ltd. · NCT04068597Clinical Efficacy of Platelet Transfusion
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT06805097DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178Early Detection of Complications During Immunotherapy for Haematological Malignancy
NA · 1 location(s) · Rigshospitalet, Denmark · NCT06377059DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Phase 2/Phase 3 · 17 location(s) · Cancer Research UK · NCT06988475Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies
NA · 4 location(s) · University Hospital, Limoges · NCT06150469The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs
Phase 2 · 5 location(s) · Helsinki University Central Hospital · NCT05159245Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Phase 2 · 7 location(s) · The University of Queensland · NCT06510699Long-term Evaluation of Fertility Preservation Options in Women in Cancer Remission or Haematological Pathology
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT07312058Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Pat
NA · 1 location(s) · Institut Claudius Regaud · NCT06797037Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapi
NA · 2 location(s) · Peter MacCallum Cancer Centre, Australia · NCT07051525Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
Phase 2 · 1 location(s) · Chi Kong Li · NCT06462248Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
Phase 2/Phase 3 · 7 location(s) · Monash University · NCT05678621Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity
Phase N/A · 1 location(s) · University College Cork · NCT06546631DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05786716DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Canc
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770037Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion
NA · 1 location(s) · Hemanext · NCT06685848Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematologic
NA · 1 location(s) · Centre Hospitalier Universitaire de Nice · NCT05379738DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)
Phase 1 · 1 location(s) · CytoMed Therapeutics Pte Ltd · NCT05302037DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05722886Safety and Feasibility of a Multidisciplinary Programme of Integrated Hospital-home Management With Early Discharge of P
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06814405
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.